SCIENTIFIC BACKGROUND

APC, BMPR1A, CDH1, CHEK2, EPCAM, GREM1, MLH1, MSH2, MSH6, MUTYH, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53

Category:

Scientific Background

Colorectal cancer is a genetic disease in which the cells in the colon or rectum divide uncontrollably forming tumors. In 2020, colorectal cancer was the 3rd most common type of cancer worldwide. Hereditary colorectal cancer accounts for about 5-10% of all colorectal cancer cases (Ferley et al., 2020). Patients with an inherited germline mutation have increased risk of developing colorectal cancer in the future.  Identifying germline mutations associated with cancer susceptibility empowers healthcare providers and patients, as it allows them to take better and more informed decisions.

 

PreSENTIA hereditary Colorectal cancer panel tests for numerous germline mutations that could cause colorectal cancers in the future. Identifying germline mutations associated with cancer susceptibility empowers healthcare providers and patients, as it allows them to take better and more informed decisions.

 

Who is this test for?

You should get tested if you meet at least one of the criteria below:

You have a personal history of colorectal cancer

You have a personal or family history of colorectal polyps

You have a personal or family history of other types of cancer

You have been diagnosed with colorectal cancer at a young age (<50)

You have first-degree relatives who have been diagnosed with colorectal cancer at a young age (<50)

You have been diagnosed with multiple primary cancers

 

How many genes are tested in this panel?

17 genes

 

How many hereditary cancer syndromes are associated with this panel?

12 Hereditary cancer syndromes are associated with this panel. These are:

Familial Adenomatous Polyposis / Attenuated Familial Adenomatous Polyposis (APC)

• Constitutional mismatch repair syndrome (EPCAM, MSH2, MSH6, MLH1, PMS2)

Hereditary diffuse gastric syndrome (CDH1)

Hereditary mixed polyposis syndrome (GREM1)

Juvenile Polyposis syndrome (SMAD4, BMPR1A)

• Li-Fraumeni syndrome (TP53)

• Li-Fraumeni syndrome 2 (CHEK2)

• Lynch syndrome (EPCAM, MLH1, MSH2, MSH6, PMS2)

• MUTYH-associated polyposis syndrome (MUTYH)

• Peutz-Jeghers syndrome (STK11)

• Polymerase proofreading associated syndrome (POLD1, POLE)

• PTEN hamartoma syndrome (PTEN)

 

Recommendations by professional bodies

The National Comprehensive Cancer Network (NCCN) recommends germline multigene panel testing for all individuals <50 years old who diagnosed with colorectal cancer and be considered for individuals who have a family history.  (NCCN, 2022)

 

References and more information: 

All the above information was taken from the National Cancer Institute, WHO, Colon Cancer Foundation

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020

GENES

APC, BMPR1A, CDH1, CHEK2, EPCAM, GREM1, MLH1, MSH2, MSH6, MUTYH, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more